Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Galanin participates in the functional regulation of the diabetic heart.

Fang P, Sun J, Wang X, Zhang Z, Bo P, Shi M.

Life Sci. 2013 Mar 28;92(11):628-32. doi: 10.1016/j.lfs.2013.01.024. Epub 2013 Feb 1. Review.

PMID:
23376774
2.

The neuropeptide galanin benefits insulin sensitivity in subjects with type 2 diabetes.

Fang P, Yu M, Shi M, He B, Zhang Z, Bo P.

Curr Protein Pept Sci. 2013 Dec;14(8):669-73. Review.

PMID:
24106965
3.

Effect of endogenous galanin on glucose transporter 4 expression in cardiac muscle of type 2 diabetic rats.

Fang P, Shi M, Guo L, He B, Wang Q, Yu M, Bo P, Zhang Z.

Peptides. 2014 Dec;62:159-63.

PMID:
25445608
4.

Beneficial effect of galanin on insulin sensitivity in muscle of type 2 diabetic rats.

He B, Shi M, Zhang L, Li G, Zhang L, Shao H, Li J, Fang P, Ma Y, Shi Q, Sui Y.

Physiol Behav. 2011 Jun 1;103(3-4):284-9. doi: 10.1016/j.physbeh.2011.02.023. Epub 2011 Feb 23.

PMID:
21352839
5.

Blocking central galanin receptors attenuates insulin sensitivity in myocytes of diabetic trained rats.

Bu L, Liu Z, Zou J, Gao X, Bao Y, Qu S.

J Neurosci Res. 2013 Jul;91(7):971-7. doi: 10.1002/jnr.23228. Epub 2013 May 7.

PMID:
23653288
6.

Galanin antagonist increases insulin resistance by reducing glucose transporter 4 effect in adipocytes of rats.

Guo L, Shi M, Zhang L, Li G, Zhang L, Shao H, Fang P, Ma Y, Li J, Shi Q, Sui Y.

Gen Comp Endocrinol. 2011 Aug 1;173(1):159-63. doi: 10.1016/j.ygcen.2011.05.011. Epub 2011 May 31.

PMID:
21664358
7.

Exercise-induced galanin release facilitated GLUT4 translocation in adipocytes of type 2 diabetic rats.

Liang Y, Sheng S, Fang P, Ma Y, Li J, Shi Q, Sui Y, Shi M.

Pharmacol Biochem Behav. 2012 Jan;100(3):554-9. doi: 10.1016/j.pbb.2011.10.026. Epub 2011 Nov 6.

PMID:
22079346
8.

Intracerebroventricular administration of galanin antagonist sustains insulin resistance in adipocytes of type 2 diabetic trained rats.

Zhang Z, Sheng S, Guo L, Li G, Zhang L, Zhang L, Shi M, Bo P, Zhu Y.

Mol Cell Endocrinol. 2012 Sep 25;361(1-2):213-8. doi: 10.1016/j.mce.2012.04.012. Epub 2012 May 4.

PMID:
22564511
9.

Combined galanin with insulin improves insulin sensitivity of diabetic rat muscles.

Bu L, Yao Q, Liu Z, Tang W, Zou J, Qu S.

J Endocrinol. 2014 Mar 17;221(1):157-65. doi: 10.1530/JOE-13-0444. Print 2014 Apr.

10.

Crosstalk between exercise and galanin system alleviates insulin resistance.

Fang P, He B, Shi M, Zhu Y, Bo P, Zhang Z.

Neurosci Biobehav Rev. 2015 Dec;59:141-6. doi: 10.1016/j.neubiorev.2015.09.012. Epub 2015 Nov 2. Review.

PMID:
26542124
11.

Effect of M35, a neuropeptide galanin antagonist on glucose uptake translated by glucose transporter 4 in trained rat skeletal muscle.

Jiang L, Shi M, Guo L, He B, Li G, Zhang L, Zhang L, Shao H.

Neurosci Lett. 2009 Dec 25;467(2):178-81. doi: 10.1016/j.neulet.2009.10.034. Epub 2009 Oct 14.

PMID:
19835935
12.

Impairment of cardiac insulin signaling and myocardial contractile performance in high-cholesterol/fructose-fed rats.

Deng JY, Huang JP, Lu LS, Hung LM.

Am J Physiol Heart Circ Physiol. 2007 Aug;293(2):H978-87. Epub 2007 Mar 30.

13.

Activated central galanin type 1 receptor alleviated insulin resistance in diabetic rat muscle.

Bu L, Chang X, Cheng X, Yao Q, Su B, Sheng C, Qu S.

J Neurosci Res. 2016 Oct;94(10):947-55. doi: 10.1002/jnr.23775. Epub 2016 Jul 13.

PMID:
27410235
14.

Akt2-Dependent Beneficial Effect of Galanin on Insulin-Induced Glucose Uptake in Adipocytes of Diabetic Rats.

Zhang Z, Fang P, Guo L, He B, Shi M, Zhu Y, Bo P.

Cell Physiol Biochem. 2017 Mar 31;41(5):1777-1787. doi: 10.1159/000471870. [Epub ahead of print]

15.

Effects of losartan in combination with or without exercise on insulin resistance in Otsuka Long-Evans Tokushima Fatty rats.

Ishizawa K, Yoshizumi M, Tsuchiya K, Takishita E, Nakaya Y, Kishi K, Ebina Y, Houchi H, Minakuchi K, Tamaki T.

Eur J Pharmacol. 2001 Nov 2;430(2-3):359-67.

PMID:
11711055
16.

The effects of galanin on neuropathic pain in streptozotocin-induced diabetic rats.

Xu X, Liu Z, Liu H, Yang X, Li Z.

Eur J Pharmacol. 2012 Apr 5;680(1-3):28-33. doi: 10.1016/j.ejphar.2012.01.011. Epub 2012 Jan 26.

PMID:
22306246
17.

Effects of valsartan on diabetic cardiomyopathy in rats with type 2 diabetes mellitus.

Yang ZH, Peng XD.

Chin Med J (Engl). 2010 Dec;123(24):3640-3.

PMID:
22166644
18.

Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment.

Falc√£o-Pires I, Leite-Moreira AF.

Heart Fail Rev. 2012 May;17(3):325-44. doi: 10.1007/s10741-011-9257-z. Review.

PMID:
21626163
19.

Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance.

Zisman A, Peroni OD, Abel ED, Michael MD, Mauvais-Jarvis F, Lowell BB, Wojtaszewski JF, Hirshman MF, Virkamaki A, Goodyear LJ, Kahn CR, Kahn BB.

Nat Med. 2000 Aug;6(8):924-8.

PMID:
10932232
20.

Galanin peptide family as a modulating target for contribution to metabolic syndrome.

Fang P, Yu M, Shi M, Zhang Z, Sui Y, Guo L, Bo P.

Gen Comp Endocrinol. 2012 Oct 1;179(1):115-20. doi: 10.1016/j.ygcen.2012.07.029. Epub 2012 Aug 14. Review.

PMID:
22909974

Supplemental Content

Support Center